Podcast: Innovations In Market Access
High-Impact Practices For A New Era Of Transformational Medicine
In Vivo welcomes Indranil Bagchi, SVP of global value and access at Novartis Oncology, and Srikant Vaidyanathan, senior partner and managing director of the Boston Consulting Group, onto the podcast to discuss the future of market access as a function in the biopharma industry.
You may also be interested in...ï»¿
Insights from Gates Medical Research Institute CEO Dr. Penny Heaton.
In Vivo visits Gates Medical Research Institute CEO Dr. Penny Heaton to review its first pipeline of drugs and vaccines to attack four of the world’s biggest killers: TB, malaria, enteric diseases and other conditions affecting maternal, newborn and child health.
Big pharma is facing a difficult US competitive landscape as its traditional customers realign to build their own redoubts of size, scale and reach.